Live Breaking News & Updates on Thomas Rademacher

Stay updated with breaking news from Thomas rademacher. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Vaccine Developers Leverage mRNA and Other Powerful Technologies

Vaccine Developers Leverage mRNA and Other Powerful Technologies
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

United States , University College , New South Wales , San Diego , United Kingdom , Paul Grint , Maravai Lifesciences , Kate Broderick , Thomas Rademacher , Drug Administration , Alexandre Le Vert Co , University College London , University Of California , Middle East , Alexandre Le Vert , Lancet Infectious Disease ,

Weekly Rounds: Vaporized Hydrogen Peroxide, Gonorrhea Treatment, Chikungunya, and More

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending January 14, 2024.
....

Thomas Rademacher , Recce Pharmaceuticals , Hydrogen Peroxide , Infection Control , Vaporized Hydrogen Peroxide , Established Sterilization Method , Established Category , Antibiotic Resistant Gonorrhea Treatment , Possible Breakthrough , Breakthrough Approach , Chikungunya Prevention , Understandingt Cell ,

A Breakthrough Approach to Chikungunya Prevention: Understanding T Cell Vaccines

In this final of 3 segments of an interview with ICT, Thomas Rademacher, Emergex co-founder, delves into T cell-based vaccines for chikungunya, likening immune programming to software, emphasizing the urgency of prevention in endemic regions.
....

City Of , United Kingdom , Thomas Rademacher , University College London , Infection Control , T Cells ,

Discussing Chikungunya Current and Future Chikungunya Vaccines

The FDA-approved vaccine for chikungunya is out, but is it a safer and more effective solution for preventing this infectious disease? What other options are coming? ICT finds out.
....

City Of , United Kingdom , Thomas Rademacher , University College London , Infection Control , Adobe Stock ,

Emergex Announces Authorisation from Philippines FDA to Initiate Phase I-II Clinical Trial of CoronaTcP™

Emergex received authorisation from the Philippines FDA to launch a Phase I-II clinical trial of CoronaTcP, its T cell-priming immune set-point ca. ....

United States , United Kingdom , Rachelle Babb , Storme Moore Thornicroft , Thomas Rademacher , Philippines Food Drug Administration , Emergex Vaccines Holding Limited , Vaccines Holding Limited , Philippines Food , Drug Administration , Chief Executive Officer , Dengue Fever , Universal Influenza , Senior Account ,